Compounds > yomogin
Page last updated: 2024-09-05

yomogin and sesquiterpenes

yomogin has been researched along with sesquiterpenes in 6 studies

Compound Research Comparison

Studies
(yomogin)		Trials
(yomogin)		Recent Studies (post-2010)
(yomogin)		Studies
(sesquiterpenes)		Trials
(sesquiterpenes)		Recent Studies (post-2010) (sesquiterpenes)
90217,4895367,668

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's5 (83.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, YN; Jeong, YS; Lee, HJ; Ryu, JH; Ryu, SY1
Kim, KM; Oak, MH; Ryu, SY1
Gumila, E; Tigno, XT1
de Guzman, F; Flora, AM; Tigno, XT1
Kim, SH; Kim, TS1
Ha, JH; Jeong, SH; Koo, SJ; Lee, KT; Park, HJ; Ryu, SY1

Other Studies

6 other study(ies) available for yomogin and sesquiterpenes

ArticleYear
Yomogin, an inhibitor of nitric oxide production in LPS-activated macrophages.
    Archives of pharmacal research, 1998, Volume: 21, Issue:4

    Topics: Animals; Artemisia; Cell Line; Dose-Response Relationship, Drug; Enzyme Induction; Enzyme Inhibitors; Guanidines; Lipopolysaccharides; Macrophages; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Plants, Medicinal; Sesquiterpenes; Sesquiterpenes, Eudesmane

1998
Yomogin inhibits the degranulation of mast cells and the production of the nitric oxide in activated RAW 264.7 cells.
    Planta medica, 2000, Volume: 66, Issue:2

    Topics: Animals; Cell Degranulation; Enzyme Inhibitors; Macrophage Activation; Macrophages; Mast Cells; Mice; Nitric Oxide; Nitric Oxide Synthase; Sesquiterpenes; Sesquiterpenes, Eudesmane

2000
In vivo microvascular actions of Artemisia vulgaris L. in a model of ischemia-reperfusion injury in the rat intestinal mesentery.
    Clinical hemorheology and microcirculation, 2000, Volume: 23, Issue:2-4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Artemisia; Blood Pressure; Capillary Leak Syndrome; Cell Adhesion; Drug Evaluation, Preclinical; Enzyme Inhibitors; Heart Rate; Hemodynamics; Hexanes; Intestines; Ischemia; Lactones; Leukocytes; Male; Mesenteric Vascular Occlusion; Microscopy, Video; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Plant Extracts; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sesquiterpenes; Sesquiterpenes, Eudesmane; Splanchnic Circulation; Water

2000
Phytochemical analysis and hemodynamic actions of Artemisia vulgaris L.
    Clinical hemorheology and microcirculation, 2000, Volume: 23, Issue:2-4

    Topics: Animals; Antihypertensive Agents; Artemisia; Blood Pressure; Chloroform; Dioxoles; Drug Evaluation, Preclinical; Epoxy Compounds; Ethanol; Gas Chromatography-Mass Spectrometry; Heart Rate; Hemodynamics; Hypertension; Lactones; Male; Mesenteric Artery, Superior; Norepinephrine; Perfusion; Plant Extracts; Plant Leaves; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Sesquiterpenes, Eudesmane; Splanchnic Circulation; Water

2000
Synergistic induction of 1,25-dihydroxyvitamin D(3)- and all-trans-retinoic acid-induced differentiation of HL-60 leukemia cells by yomogin, a sesquiterpene lactone from Artemisia princeps.
    Planta medica, 2002, Volume: 68, Issue:10

    Topics: Antineoplastic Agents; Artemisia; Calcitriol; Cell Differentiation; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Flow Cytometry; Fluorescent Antibody Technique; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Nitric Oxide Synthase; Phytotherapy; Sesquiterpenes; Sesquiterpenes, Eudesmane; Tretinoin

2002
Induction of apoptosis by yomogin in human promyelocytic leukemic HL-60 cells.
    Biological & pharmaceutical bulletin, 2004, Volume: 27, Issue:7

    Topics: Apoptosis; Artemisia; Cell Proliferation; HL-60 Cells; Humans; Plant Extracts; Sesquiterpenes; Sesquiterpenes, Eudesmane

2004